Brooks Lab Peer Comparison

NSE: BROOKS | BSE: 533543

₹66.45

₹0.96 (1.47%)

As on 05-Nov-2026IST

Market cap

₹195 Cr

Revenue (TTM)

₹83 Cr

P/E Ratio

14.8

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	195	17,993	18,414	17,641	17,064
Revenue (₹ Cr)	83	1,842	2,287	2,654	3,330
Net Profit (₹ Cr)	4.57	308.62	678.07	859.38	720.77
Net Margin (%)	5.42	16.63	28.10	30.42	21.60
RoE (%)	11.09	11.81	19.73	18.58	18.93
Price to Earnings	14.78	54.12	27.68	20.53	24.12
Price-To-Book	1.57	6.70	5.01	4.02	4.12

Income Statement (₹ Cr)

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	83.19	1,841.62	2,287.33	2,654.29	3,329.63
Total Income	84.32	1,855.87	2,413.29	2,825.39	3,337.47
Total Expenditure	77.39	1,328.95	1,490.75	1,681.39	2,168.88
EBITDA	5.80	512.67	796.58	972.90	1,160.75
Depreciation	1.61	130.47	78.10	57.71	285.40
EBIT	4.18	382.20	718.48	915.19	875.35
Interest	0.74	49.12	0.88	8.91	187.51
Other Income	1.13	14.25	125.96	171.10	7.84
Exceptional Items	0.00	11.73	0.00	82.90	-53.14
Profit before Tax	4.57	359.06	843.56	1,160.28	642.54
Provision for Tax	0.00	50.44	165.49	300.90	-78.23
Profit after Tax	4.57	308.62	678.07	859.38	720.77

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	122.66	2,757.68	3,586.42	4,385.41	4,144.34
Minority Interest	0.00	0.00	-12.71	0.00	-10.85
Non-Current Liabilities	3.70	363.37	28.74	222.21	758.48
Current Liabilities	21.81	1,016.50	385.94	685.36	2,681.14
Total Liabilities	148.17	3,705.61	4,037.51	4,921.88	7,246.72

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	106.94	2,763.86	1,291.22	905.21	5,578.78
Current Assets	37.42	1,277.15	2,585.66	4,024.56	1,800.86
Total Assets	148.17	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	7.28	657.97	0.57	2.50	2,309.68
Net Current Assets	15.60	260.65	2,199.72	3,339.20	-880.28
Contingent Liabilities	122.94	160.01	17.53	370.49	51.57

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	9.29	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-2.92	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	0.17	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	6.54	29.88	-105.52	-392.41	-145.00

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	21.72	11.43	24.97	23.39	14.47
ROE (%)	11.09	11.81	19.73	18.58	18.93
ROA (%)	3.36	8.09	18.69	17.36	9.78
EBIT Margin (%)	5.03	20.75	31.41	34.48	26.29
Net Margin (%)	5.42	16.63	28.10	30.42	21.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	-7.71	37.26	15.01	11.75	11.06
EBIT Growth (%)	-32.07	56.89	18.45	21.45	13.71
Net Profit Growth (%)	-22.20	127.86	19.61	2.39	60.98
EPS Growth (%)	927.88	5.65	17.73	13.17	80.38
Book Value Growth (%)	25.03	9.67	26.75	-0.34	36.71

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	14.78	56.99	27.68	22.11	22.33
Price / Book Value	1.57	6.70	5.01	4.02	4.12
Dividend Yield (%)	0.00	0.07	0.33	1.94	0.00
EV/EBITDA	33.65	36.29	21.85	14.94	16.63
Market Cap (₹ Cr)	110.43	6,819.66	11,439.22	21,592.90	17,980.08

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.01	0.08	0.00	0.00	0.10
Short term debt to equity ratio	0.05	0.16	0.00	0.00	0.12
Current Ratio	1.72	1.26	6.70	5.87	0.67
Quick Ratio	1.21	0.82	5.59	5.23	0.49
Interest Coverage	7.19	8.31	959.59	131.22	4.43

	Brooks Lab	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	19.37	29.09	36.10	9.10	18.98
Asset Turnover	0.61	0.48	0.63	0.54	0.45
Receivable days	76.86	113.81	121.68	26.06	63.88
Inventory Days	43.05	84.76	63.83	65.95	43.27
Payable days	89.64	101.94	108.28	81.01	151.85
Cash Conversion Cycle	30.27	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.